Market closedNon-fractional
IDEXX Laboratories/IDXX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About IDEXX Laboratories
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Ticker
IDXX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Westbrook, United States
Employees
11,000
Website
www.idexx.com
IDXX Metrics
BasicAdvanced
$39B
Market cap
45.61
P/E ratio
$10.32
EPS
1.33
Beta
-
Dividend rate
Price and volume
Market cap
$39B
Beta
1.33
Financial strength
Current ratio
1.57
Quick ratio
0.945
Long term debt to equity
39.568
Total debt to equity
60.283
Interest coverage (TTM)
30.33%
Management effectiveness
Return on assets (TTM)
22.63%
Return on equity (TTM)
71.91%
Valuation
Price to earnings (TTM)
45.609
Price to revenue (TTM)
10.5
Price to book
24.74
Price to tangible book (TTM)
24.74
Price to free cash flow (TTM)
49.084
Growth
Revenue change (TTM)
8.57%
Earnings per share change (TTM)
24.27%
3-year revenue growth (CAGR)
9.23%
3-year earnings per share growth (CAGR)
9.92%
What the Analysts think about IDXX
Analyst Ratings
Majority rating from 13 analysts.
IDXX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$964M
6.92%
Net income
$236M
21.08%
Profit margin
24.42%
13.21%
IDXX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.67
$2.53
$2.32
$2.81
-
Expected
$2.47
$2.37
$2.12
$2.67
$2.87
Surprise
8.19%
6.75%
9.46%
5.16%
-
IDXX News
AllArticlesVideos
Looking For Fast Growth In Healthcare? IDEXX Has You Covered
Seeking Alpha·4 weeks ago
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
Business Wire·1 month ago
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
PRNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for IDEXX Laboratories stock?
IDEXX Laboratories (IDXX) has a market cap of $39B as of July 27, 2024.
What is the P/E ratio for IDEXX Laboratories stock?
The price to earnings (P/E) ratio for IDEXX Laboratories (IDXX) stock is 45.61 as of July 27, 2024.
Does IDEXX Laboratories stock pay dividends?
No, IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next IDEXX Laboratories dividend payment date?
IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders.
What is the beta indicator for IDEXX Laboratories?
IDEXX Laboratories (IDXX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell IDEXX Laboratories stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.